Summit Global Investments’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$796K Sell
30,919
-844
-3% -$19.6K 0.04% 255
2026
Q1
$653K Hold
31,763
0.04% 283
2025
Q4
$753K Sell
31,763
-1,914
-6% -$46.6K 0.04% 248
2025
Q3
$839K Buy
33,677
+24,670
+274% +$531K 0.05% 224
2025
Q2
$207K Buy
+9,007
New +$209K 0.01% 446

Other funds holding PRVA

Summit Global Investments's PRVA Position: Q2 2026 in Review

Summit Global Investments reduced its Privia Health (PRVA) stake by 2.7% in Q2 2026, selling an estimated $19.6K and leaving 30,919 shares worth $796K. The position accounts for 0.04% of the portfolio, ranked #255.

Summit Global Investments first reported a position in PRVA in Q2 2025 and has held it in 5 quarters since. The position peaked at $839K in Q3 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Summit Global Investments held 30,919 shares of Privia Health worth $796K as of Q2 2026.
  • Summit Global Investments sold 844 Privia Health shares in Q2 2026, an estimated $19.6K.
  • Privia Health made up 0.04% of Summit Global Investments's portfolio in Q2 2026, its #255 holding.
  • Summit Global Investments first reported a position in Privia Health in Q2 2025 and has held it in 5 quarters since.
  • Summit Global Investments's Privia Health position peaked at $839K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.